IDEXX Laboratories Inc. income statement & cash flow
In the fiscal year ended Dec 31, 2025, IDEXX Laboratories Inc. reported net income of $1.06B on revenue of $4.30B. Operating cash flow was $1.18B and capital expenditures were $124.68M, leaving $1.06B of free cash flow (operating cash flow minus capital expenditures).
Income statement and cash flow summary
| Fiscal year ended | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.78B | $1.97B | $2.21B | $2.41B | $2.71B | $3.22B | $3.37B | $3.66B | $3.90B | $4.30B |
| Gross profit | $975.44M | $1.10B | $1.24B | $1.37B | $1.57B | $1.89B | $2.00B | $2.19B | $2.38B | $2.66B |
| Operating income | $350.24M | $413.03M | $491.33M | $552.85M | $694.52M | $932.03M | $898.76M | $1.10B | $1.13B | $1.36B |
| Net income | $222.04M | $263.14M | $377.03M | $427.72M | $581.78M | $744.85M | $679.09M | $845.04M | $887.87M | $1.06B |
| Diluted EPS | $2.44 | $2.94 | $4.26 | $4.89 | $6.71 | $8.60 | $8.03 | $10.06 | $10.67 | $13.08 |
| Operating cash flow | $338.94M | $373.28M | $400.08M | $459.16M | $648.06M | $755.55M | $542.98M | $906.51M | $929.00M | $1.18B |
| Capital expenditures | $64.79M | $74.38M | $115.75M | $154.97M | $106.96M | $119.55M | $148.84M | $133.63M | $120.92M | $124.68M |
| Reported in | 10-K 2019 | 10-K 2020 | 10-K 2021 | 10-K 2022 | 10-K 2023 | 10-K 2024 | 10-K 2025 | 10-K 2026 | 10-K 2026 | 10-K 2026 |
Margins
Each figure divided by revenue for the same fiscal year.
| Fiscal year ended | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| Dec 2025 | 61.8% | 31.6% | 24.6% |
| Dec 2024 | 61.0% | 29.0% | 22.8% |
| Dec 2023 | 59.8% | 30.0% | 23.1% |
| Dec 2022 | 59.5% | 26.7% | 20.2% |
| Dec 2021 | 58.8% | 29.0% | 23.2% |
Source: SEC EDGAR XBRL company facts for CIK 874716 (raw data). Most recent filing in this dataset: 10-Q filed Nov 2, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.